CVR: 32438784
DKK 997,234
Gross profit
Net result: DKK 243,660
Jonas Hink
CVR · view ownership and management
Director registered: Jonas Hink
CVR · 25/02/2019
View the full event history
BIOPHARM FORWARD ApS is a Danish company of the type Anpartsselskab based in Espergærde, founded in 2009. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jonas Hink. The company is owned by Jonas Hink. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK 997,234 and a net result of DKK 243,660 compared with DKK 385,061 the year before. Equity in the 2025 report amounted to DKK 1,741,315.
Selskabets formål er at drive konsulentvirksomhed indenfor life science området samt udøve aktiviteter i tilknytning hertil.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202526/08/2024 – 25/08/2025 | 997 t. | 244 t. | 2.2 mio. | 1.7 mio. | 1 | |
| 202426/08/2023 – 25/08/2024 | 1.1 mio. | 385 t. | 2.1 mio. | 1.6 mio. | 1 | |
| 202326/08/2022 – 25/08/2023 | 550 t. | -107 t. | 1.7 mio. | 1.4 mio. | 1 | |
| 202226/08/2021 – 25/08/2022 | 584 t. | 156 t. | 1.8 mio. | 1.6 mio. | 1 | |
| 202126/08/2020 – 25/08/2021 | 928 t. | 1.5 mio. | 1.8 mio. | 1.6 mio. | 1 | |
| 202026/08/2019 – 25/08/2020 | 182 t. | 146 t. | 554 t. | 209 t. | 1 | |
| 201926/08/2018 – 25/08/2019 | 291 t. | 201 t. | 418 t. | 171 t. | 0 | |
| 201826/08/2017 – 25/08/2018 | -2 t. | -2 t. | 693 | -30 t. | - | |
| 201726/08/2016 – 25/08/2017 | -2 t. | -2 t. | 570 | -28 t. | - | |
| 201626/08/2015 – 25/08/2016 | -1 t. | -1 t. | 797 | -26 t. | - | |
| 201526/08/2014 – 25/08/2015 | -2 t. | -2 t. | 968 | -25 t. | - | |
| 201426/08/2013 – 25/08/2014 | -2 t. | -2 t. | 3 t. | -24 t. | - | |
| 201326/08/2012 – 25/08/2013 | -2 t. | -2 t. | 5 t. | -21 t. | - | |
| 201226/08/2011 – 25/08/2012 | -11 t. | -47 t. | 12 t. | -19 t. | - |
Compared to 1.149 companies in Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningBIOPHARM FORWARD ApS was founded on 26 August 2009.
BIOPHARM FORWARD ApS is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (industry code 749990).
BIOPHARM FORWARD ApS had 0 employees in 2011 according to the Danish CVR register.
BIOPHARM FORWARD ApS is owned by Jonas Hink.
In 2025, BIOPHARM FORWARD ApS reported a gross profit of DKK 997,234.
The management of BIOPHARM FORWARD ApS consists of Jonas Hink.
Claim this page to add your logo and social links. Free to get started.
BIOPHARM FORWARD ApS has published its annual report for 2025. Gross profit came to DKK 997,234, and the net result was DKK 243,660.
BIOPHARM FORWARD ApS has published its annual report for 2024. Gross profit came to DKK 1,056,751, and the net result was DKK 385,061.
BIOPHARM FORWARD ApS has published its annual report for 2023. Gross profit came to DKK 549,847, and the net result was DKK -107,301.
BIOPHARM FORWARD ApS has published its annual report for 2022. Gross profit came to DKK 584,101, and the net result was DKK 156,128.
BIOPHARM FORWARD ApS has published its annual report for 2021. Gross profit came to DKK 928,008, and the net result was DKK 1,456,847.
BIOPHARM FORWARD ApS has published its annual report for 2020. Gross profit came to DKK 181,875, and the net result was DKK 145,891.
BIOPHARM FORWARD ApS has published its annual report for 2019. Gross profit came to DKK 291,460, and the net result was DKK 201,331.
As of February 25, 2019, Jonas Hink is registered as director of BIOPHARM FORWARD ApS.
As of February 25, 2019, Bodil Elisabeth Fransiska Ørkild has stepped down as director of BIOPHARM FORWARD ApS.
BIOPHARM FORWARD ApS has published its annual report for 2018. Gross profit came to DKK -1,877, and the net result was DKK -1,877.
BIOPHARM FORWARD ApS has published its annual report for 2017. Gross profit came to DKK -1,727, and the net result was DKK -1,727.
BIOPHARM FORWARD ApS has published its annual report for 2016. Gross profit came to DKK -1,171, and the net result was DKK -1,171.
BIOPHARM FORWARD ApS has published its annual report for 2015. Gross profit came to DKK -1,776, and the net result was DKK -1,772.
BIOPHARM FORWARD ApS has published its annual report for 2014. Gross profit came to DKK -2,222, and the net result was DKK -2,214.
As of December 14, 2014, Jonas Hink is registered as an owner of BIOPHARM FORWARD ApS with an ownership share of 100%.
BIOPHARM FORWARD ApS has published its annual report for 2013. Gross profit came to DKK -2,016, and the net result was DKK -1,974.
BIOPHARM FORWARD ApS has published its annual report for 2012. Gross profit came to DKK -11,226, and the net result was DKK -47,010.
As of January 25, 2012, Bodil Elisabeth Fransiska Ørkild is registered as director of BIOPHARM FORWARD ApS.
As of January 25, 2012, Jonas Hink has stepped down as director of BIOPHARM FORWARD ApS.
As of October 1, 2011, Jonas Hink is registered as director of BIOPHARM FORWARD ApS.
As of September 30, 2011, Bodil Elisabeth Fransiska Ørkild has stepped down as director of BIOPHARM FORWARD ApS.
As of September 1, 2010, Bodil Elisabeth Fransiska Ørkild is registered as director of BIOPHARM FORWARD ApS.
As of August 31, 2010, Jonas Hink has stepped down as director of BIOPHARM FORWARD ApS.
As of August 26, 2009, Jonas Hink is registered as director of BIOPHARM FORWARD ApS.
BIOPHARM FORWARD ApS was founded on August 26, 2009.
Companies in the same industry and area
CVR 40965858
CVR 42147451
CVR 25987136
CVR 39835975
CVR 36069198
